News & Reports

Have some news you want to share with the Oregon Bio community?  Fill out our submission form.

Life Technologies Acquires Pinpoint Genomics and CLIA-Approved Lung Cancer Test

Early-Stage Non-Small Cell Lung Cancer Test Identifies Patients at High Risk for Progression and Mortality Following Surgery
Improved Application of Early Treatment May Save Lives, Reduce Costs Associated with Late-Stage, Extended Therapies
Life Technologies Poised to Offer Clinical Diagnostic Content Across Genome, Proteome and Transcriptome

CARLSBAD, Calif., July 25, 2012 /PRNewswire/ — Life Technologies Corporation (NASDAQ: LIFE) today announced the acquisition of Pinpoint Genomics, Inc., and its early-stage non-small cell lung cancer test that can help doctors identify those early-stage patients at high […]

July 9, 2012 |

HemCon Adds Barry Starkman as CEO

June 6, 2012

“I look forward to working with the team in a timely exit from Chapter 11 and then helping HemCon realize its potential as a highly successful and viable enterprise.”

“As we reorganize and restructure with the objective of successfully exiting Chapter 11, Barry is an extremely important addition to the HemCon team. His leadership and expertise will prove valuable in realizing the full potential of our lyophilized plasma program (LyP program), and in developing the optimal strategy for the […]

Statement by the Press Secretary on H.R. 33, H.R. 2297, and S. 3187

THE WHITE HOUSE
Office of the Press Secretary
FOR IMMEDIATE RELEASE
July 9, 2012

Statement by the Press Secretary on H.R. 33, H.R. 2297, and S. 3187

On Monday, July 9, 2012, the President signed into law:

H.R. 33, the “Church Plan Investment Clarification Act,” which amends the Securities Act of 1933 to provide specifically for an exemption from SEC requirements in connection with church pension plans participating in collective trust funds;

H.R. 2297, which makes technical amendments to the District of Columbia Code to facilitate development […]

Analysis highlights ‘capital gaps’ hamstringing Oregon business potential

June 11, 2012

The study, “Oregon Capital Scan: A Developing Ecosystem,” identified eight so-called “capital gaps” affecting employers across the spectrum of Oregon industries.

The study was commissioned by Oregon State Treasurer Ted Wheeler and The Oregon Community Foundation. Other support that made the report possible came from Meyer Memorial Trust, Business Oregon and Portland-based CTC Consulting.

The primary goal: Provide policymakers and financial leaders with a clearer understanding of the state’s business capital landscape, which will foster well-educated decisions to strengthen the […]

Galena Biopharma Strengthens Clinical Management Team

May 3, 2012

“With her outstanding background as an oncology physician and scientist, as well as a biopharmaceutical company executive in small and large companies, Dr. Mazanet brings a wealth of knowledge, expertise and insight to Galena’s management team, ” said Mark J. Ahn, Ph.D., President and CEO. “Her experience and leadership will be instrumental in driving our clinical programs, coordinating with our Scientific Advisory Board and site investigators, and communicating our mission among advocacy groups.”

Dr. Mazanet is an oncologist with […]

Galena Biopharma Announces Expansion of Scientific Advisory Board

May 10, 2012

“Dr. Figlin is a tremendous asset to Galena’s Scientific Advisory Board, as he is a recognized leader and expert in advancing novel cancer therapies,” said Rosemary Mazanet, M.D., Ph.D., Executive Vice President and Chief Medical Officer. “We look forward to his input and guidance as we reach the next level of success with our oncology treatments.”

Dr. Figlin is a prolific researcher known for advancing cancer therapies. His expertise has resulted in the development of novel anti-cancer drugs that […]

MolecularMD Closes $6 Million Series B Financing and Announces Ensuing Growth Initiatives

Dan Snyder, President and COO of MolecularMD commented, “We are grateful for the continued support of Ballast Point Ventures, and we are pleased to be adding oncology-focused Nextech Invest to our investor group. We are well positioned to put the capital to work as we further define our presence in the high growth molecular diagnostics market. MolecularMD has over six years of proven performance, having provided testing in worldwide pivotal trials for several of the most successful targeted cancer therapies […]

New Report Shows Oregon Clinical Trials Benefit State’s Health and Economy

Working in collaboration with Oregon’s university medical schools, hospitals and clinical research centers, biopharmaceutical companies are conducting or have conducted since 1999 more than 2,300 clinical trials of new medicines in the state, a report released today shows.

Clinical trials are critical to the development of new medicines, accounting for up to seven years of the 10 to 15 years required to develop a new drug, according to “Research in Your Backyard: Pharmaceutical Clinical Trials in Oregon.”

The report – compiled by […]

Oregon Bioscience Association Announces Board Officers and Directors for 2012

FOR IMMEDIATE RELEASE – March 20, 2012

CONTACT: Dennis McNannay, Executive Director, Oregon Bioscience Assoc., (503) 548-4432
Dianne Danowski Smith, Oregon Bio board member, (503) 201-7019

OREGON BIOSCIENCE ASSOCIATION ANNOUNCES BOARD OFFICERS AND DIRECTORS FOR 2012

(Portland, Ore.) — Peter Murray, site executive and vice president for one of Oregon’s largest medical device manufacturers, Welch Allyn, has been appointed chairman of the Oregon Bioscience Association (Oregon Bio) board of directors. Executive committee members include Ryan Dunlap, treasurer, Moss Adams LLP; and Michael Phillips, secretary and […]

Scientific advisers to the C.D.C. have been discussing the details of federal guidance on who qualifies for a Pfizer-BioNTech booster shot and why. A recommendation by the panel is expected… [...]

NIH vouches for new kidney disease diagnostic that doesn't rely on faulty race-based calculations apark Thu, 09/23/2021 - 14:44 [...]

The discussion, which continues on Thursday, could result in most Americans qualifying for an extra shot, or only a select few. [...]

The most common method of assessing the condition may make Black patients seem less ill than they really are, some experts say. A new report calls for scrapping the formula. [...]

A lawsuit brought on by the Montana Medical Association is challenging the state's ban on employer vaccine mandates. The association, along with other hospitals and patient groups, filed a lawsuit Wednesday… [...]